AI/ML technologies are revolutionizing pharmaceutical formulation by optimizing excipient selection and predicting stability, reducing time and resources needed for development. Poor solubility of ...

Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially viable dosage forms, rarely a simple process. Image Credit: ...

LONDON--(BUSINESS WIRE)--The Pharmaceutical Formulation Equipment market will register an incremental spend of about USD 7.35 billion, growing at a CAGR of 8.42% during the five-year forecast period.

In the quest to develop safe and effective medicines, pharmaceutical companies rely on the precise combination of active pharmaceutical ingredients (APIs) and excipients. These crucial components play ...

The global oral solid dosage pharmaceutical formulation market is on a trajectory of significant expansion, projected to grow from USD 6,29,582.6 million in 2024 to USD 8,95,636.0 million by 2034.